There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality.

Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

I and i

다중혈관 관상동맥 환자에서 y-문합을 이용하여 양쪽 내흉동맥만을 사용한 우회술의 조기 성적

抗原变异可使得多种致病微生物易于逃避宿主免疫应答。表达在感染红细胞表面的恶性疟原虫红细胞表面蛋白1（PfPMP1）与感染红细胞、内皮细胞、树突状细胞以及胎盘的单个或多个受体作用，在黏附及免疫逃避中起关键的作用。每个单倍体基因组var基因家族编码约60种成员，通过启动转录不同的var基因变异体为抗原变异提供了分子基础。

疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A

Sustainable economic and industrial growth requires safe, sustainable resources of energy. For the future re-arrangement of a sustainable economy to biological raw materials, completely new approaches in research and development, production, and economy are necessary. The ‘first-generation’ biofuels appear unsustainable because of the potential stress that their production places on food commodities. For organic chemicals and materials these needs to follow a biorefinery model under environmentally sustainable conditions. Where these operate at present, their product range is largely limited to simple materials (i.e. cellulose, ethanol, and biofuels). Second generation biorefineries need to build on the need for sustainable chemical products through modern and proven green chemical technologies such as bioprocessing including pyrolysis, Fisher Tropsch, and other catalytic processes in order to make more complex molecules and materials on which a future sustainable society will be based. This review focus on cost effective technologies and the processes to convert biomass into useful liquid biofuels and bioproducts, with particular focus on some biorefinery concepts based on different feedstocks aiming at the integral utilization of these feedstocks for the production of value added chemicals.

http://staff.cimap.res.in/PublicationFiles/Renew_Sustain_Energ_Rev_14_578.pdf

Production of first and second generation biofuels: A comprehensive review

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S. A. S. Nagar,Mohali, Punjab-160 062, India, Institute of Biochemistry, Faculty of Medicine, Polytechnic University, Via Ranieri 67, IT-60100 Ancona, Italy,Green Biotechnology Research Group, The Special Division for Human Life Technology, National Institute of Advanced Industrial Science andTechnology, 1-8-31 Midorigaoka, Ikeda, Osaka-563-8577, Japan, and Department of Medicinal Chemistry & Natural Products,The Hebrew University of Jerusalem, School of Pharmacy-Faculty of Medicine, Jerusalem 91120, IsraelReceived March 2, 2004

Chitosan chemistry and pharmaceutical perspectives.

The present invention relates to a group of substituted-7-azabicyclo--[2.2.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing said substituted-7-azabicyclo--[2 2.1]heptyl derivatives. The present invention also relates to certain intermediates for producing such substituted-7-azabicyclo-[2 2.1]heptyl derivatives, as well as a synthetic method for producing such intermediates. The present invention also relates to pharmaceutical compositions comprising such substituted-7-azabicyclo-[2.2.1]heptyl deriva-tives, as well as their use as medicaments for the treatment of diseases mediated by a Nicotinic Acetylcholine Receptor or a receptor being a member of the Neurotransmitter--gated Ion Channel Superfamily, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and nicotine addiction.

Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions

This invention provides 2-azabicyclo[3.1.1]heptyl derivatives, and methods for producing them, which are useful therapeutic agents for preventing or treating central nervous system disorders and disease mediated by a Nicotinic Acetylcholine Receptor such as, but not limited to, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, dementia, pain and nicotine addiction.

1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

Novel peralkylated imidazolium ionic liquids bearing alkoxy and/or alkenyl side chains have been synthesized and studied. Different synthetic routes towards the imidazoles and the ionic liquids comprising bromide, iodide, methanesulfonate, bis(trifluoromethylsulfonyl) imide ([NTf2](-)), and dicyanamide {[N(CN)(2)](-)} as the anion were evaluated, and this led to a library of analogues, for which the melting points, viscosities, and electrochemical windows were determined. Incorporation of alkenyl moieties hindered solidification, except for cations with high symmetry. The alkoxy-derivatized ionic liquids are often crystalline; however, room-temperature ionic liquids (RTILs) were obtained with the weakly coordinating anions [N(CN)(2)](-) and [N(CN)(2)](-). For the viscosities of the peralkylated RTILs, an opposite trend was found, that is, the alkoxy derivatives are less viscous than their alkenyl-substituted analogues. Of the crystalline compounds, X-ray diffraction data were recorded and related to their molecular properties. Upon alkoxy substitution, the electrochemical cathodic limit potential was found to be more positive, whereas the complete electrochemical window of the alkenyl-substituted imidazolium salts was shifted to somewhat more positive potentials.

Synthesis and Properties of Alkoxy‐ and Alkenyl‐Substituted Peralkylated Imidazolium Ionic Liquids

A Convenient Synthesis of Dialkyl [[2-(Bromomethyl)aziridin-1-yl]methyl]phosphonates, New Heterocyclic β-Azaphosphonates.

This invention relates generally to new findings to improveme a method of thermal energy storage or heat pump, i.e. increase the thermal energy from an external heat source, using a reversible condensation reaction with an inorganic oxoacid compound. It accordingly provides components to be used in said improved process as well as the use thereof in the aforementioned method, including the use in the manufacture of products of the condensation products or in the manufacture of the hydrolysis products.

Christian V. Stevens

Papers

Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions

1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

Synthesis and Properties of Alkoxy‐ and Alkenyl‐Substituted Peralkylated Imidazolium Ionic Liquids

A Convenient Synthesis of Dialkyl [[2-(Bromomethyl)aziridin-1-yl]methyl]phosphonates, New Heterocyclic β-Azaphosphonates.

Membranes, azeotropic & catalytic components